Novel nano antibody electrochemical immunosensor as well as preparation method and application thereof
By using nano-antibody and carboxy carbon nanotube modified glass carbon electrodes in electrochemical immunosensors, high specificity and stability detection of the new crown S protein is achieved, and the problem of insufficient detection stability and sensitivity in the prior art is solved. , suitable for microbial identification in sewage.
Patent Information
- Application Number
- CN202411096763.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-08-12
AI Technical Summary
Existing electrochemical immunosensors have poor stability and sensitivity in microbial detection in wastewater, and the commonly used detection methods have long cycles, high costs and low safety, so they cannot effectively identify a variety of pathogenic microorganisms and pathogenic viruses.
Using nano-antibody electrochemical immunosensor, the nano-antibody is immobilized on a glassy carbon electrode modified by carboxy carbon nanotubes, and the specific binding of the nano-antibody to the target virus protein is converted into an electrical signal, improving detection stability and sensitivity.
It realizes high specificity, stability and sensitivity detection of the new crown S protein, reduces the detection limit, improves the detection efficiency and safety, and is suitable for microbial identification in sewage.
Smart Images

Figure CN118937446A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of microorganism identification and detection in the environment, and in particular to a novel nano-antibody electrochemical immunosensor and a preparation method and application thereof. Background Art
[0002] There are many kinds of microorganisms in the environment, especially in water bodies, which can cause a variety of diseases and pose a threat to human health. Among them, pathogenic bacteria include Escherichia coli, Salmonella, Campylobacter, Helicobacter and Vibrio, and pathogenic viruses include enterovirus, adenovirus, hepatitis virus, rotavirus, etc. These pathogenic bacteria and pathogenic viruses may cause various diseases, so it is necessary to test the environment, especially the water environment, to screen out possible viral hazards and facilitate subsequent disease prevention and control.
[0003] Since there are many types of pathogenic microorganisms in sewage, their abundance is low, their risks are high, and there are many interfering substances, the commonly used detection methods such as PCR (polymerase chain reaction) have problems such as long cycle, high cost, and low safety when applied to sewage detection. Therefore, it is necessary to develop a detection method with strong specificity, simplicity, rapidity, and high safety. However, the stability and sensitivity of the current electrochemical immunosensor are poor, resulting in its low practicality. Summary of the invention
[0004] In order to solve the above problems, the present invention provides a novel nano-antibody electrochemical immunosensor and a preparation method and application thereof.
[0005] In the first aspect, a novel nano-antibody electrochemical immunosensor comprises: a biorecognition element for identifying a target protein, and a substrate electrode for carrying the biorecognition element and converting the interaction between the biorecognition element and the target protein into an electrical signal;
[0006] The biorecognition element is a nano-antibody; the substrate electrode is a glassy carbon electrode modified with carboxyl carbon nanotubes;
[0007] The nanobody is obtained by recombining the gene of the virus containing the target protein with a prokaryotic expression vector to obtain a recombinant vector, and then expressing the recombinant vector in a prokaryotic manner;
[0008] The target protein is the new coronavirus S protein RBD, and the gene sequence of the gene of the virus containing the target protein is shown in SEQ ID NO: 1.
[0009] Description: Fixing the nanoantibody on the electrode surface can form a biorecognition interface. When a sample containing the target viral protein (i.e., the new coronavirus S protein in the present invention) contacts the electrode surface fixed with the nanoantibody, the nanoantibody specifically binds to the viral protein to form an antigen-antibody complex. This specific binding event will cause the charge distribution on the electrode surface to change, generating a detectable electrochemical signal, thereby realizing the detection process; through the above method, the characteristics of the nanoantibody can be utilized to improve the detection stability of the sensor, so that the thermal stability and chemical stability of the sensor are better; through the modification of carboxyl carbon nanotubes, a carrier for connecting the nanoantibody and the glassy carbon electrode can be provided. At the same time, the carboxyl carbon nanotubes have an amplification function for the signal of the glassy carbon electrode, which can improve the detection sensitivity of the sensor.
[0010] The above-mentioned anti-COVID-19 S protein RBD antibodies are well representative, enabling the sensor to detect the new coronavirus.
[0011] Furthermore, the prokaryotic expression vector is a pET25b vector.
[0012] Description: pET25b vector can efficiently express the inserted gene under the action of relevant types of enzymes, and the insertion position can be adjusted by changing the restriction site to facilitate recombination. It also carries a polyhistidine tag (His-tag) to facilitate purification, so pET25b vector is selected.
[0013] In a second aspect, the present invention provides a method for preparing a novel nano-antibody electrochemical immunosensor, comprising:
[0014] S1. Preparation of anti-COVID-19 S protein RBD antibodies;
[0015] S2, using carboxylated multi-walled carbon nanotubes to modify glassy carbon electrodes;
[0016] S3. Load the anti-COVID-19 S protein RBD antibody onto the glassy carbon electrode to obtain the sensor.
[0017] Furthermore, the S1, preparation of anti-COVID-19 S protein RBD antibodies comprises:
[0018] S1-1, recombining the gene of the virus containing the target protein with the pET25b vector to synthesize a recombinant vector;
[0019] S1-2. Transfer the recombinant vector to E.coli.DH5α bacteria for induced expression and purification to obtain anti-COVID-19 S protein RBD antibody.
[0020] Furthermore, the induction expression conditions in S1-2 are: using isopropyl-β-D-thiogalactoside as an inducer, the concentration of isopropyl-β-D-thiogalactoside is 0.4~0.6M, the induction time is 11~13h, and the induction temperature is 15~25°C; during the purification process, the concentration of the imidazole solution used for eluting the anti-new crown S protein RBD antibody is 180~210mM.
[0021] Note: The above-mentioned induced expression condition parameters are suitable for the expression of the above-mentioned anti-COVID-19 S protein RBD antibody. These parameters are more preferred, so that the obtained nanoantibodies have higher concentration and better purity.
[0022] Furthermore, the S2, using carboxylated multi-walled carbon nanotubes to modify the substrate electrode comprises:
[0023] S2-1, dispersing the carboxylated multi-walled carbon nanotubes in an N,N-dimethylformamide solution to obtain a dispersion;
[0024] S2-2, evenly drop the dispersion onto the glassy carbon electrode and let it dry to obtain a carboxylated multi-walled carbon nanotube modified substrate electrode.
[0025] Description: N,N-dimethylformamide solution has good dispersibility and stability, and can stably disperse carboxylated multi-walled carbon nanotubes on the surface of glassy carbon electrode to prevent agglomeration.
[0026] Furthermore, the S3, loading the anti-COVID-19 S protein RBD antibody onto the glassy carbon electrode to obtain the sensor comprises:
[0027] S3-1, using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide 2-morpholineethanesulfonic acid buffer to activate the glassy carbon electrode, and then rinse it with phosphate buffer saline for use;
[0028] S3-2, mixing the anti-COVID-19 S protein RBD antibody in phosphate buffered saline to form an antibody solution;
[0029] S3-3. After mixing the antibody solution with the glassy carbon electrode treated in S3-1 and letting it stand, take out the glassy carbon electrode and immerse it in a bovine serum albumin solution for incubation, and then wash the glassy carbon electrode with a phosphate buffered saline solution to obtain the sensor.
[0030] Note: The above steps can first activate the glassy carbon electrode, and by introducing active group amide bonds on its surface, it can provide an anchor point for the subsequent fixation of biomolecules, thereby improving the binding efficiency and stability of biomolecules to the electrode surface.
[0031] In the third aspect, the present invention provides an application of a new type of nano-antibody electrochemical immunosensor, which is used to detect the new coronavirus S protein in water.
[0032] The above-mentioned water bodies include water bodies in various environments, including sewage, surface water, drinking water, etc.
[0033] The detection method includes: taking 1 mL of water sample, and adding 0.07 ng / mL and 0.1 ng / mL of new coronavirus S protein to the water sample, respectively, placing the sensor of the present invention in the water sample for incubation, recording the peak current response before and after incubation, and calculating the recovery rate of the immunosensor for different concentrations of new coronavirus S protein.
[0034] The beneficial effects of the present invention are:
[0035] The present invention can utilize nano antibodies to improve the detection stability of the sensor, so that the thermal stability and chemical stability of the sensor are both better; through the modification of carboxyl carbon nanotubes, a carrier for connecting the nano antibodies and the glassy carbon electrode can be provided, and at the same time, the carboxyl carbon nanotubes have an amplification function for the signal of the glassy carbon electrode, which can improve the detection sensitivity of the sensor; and the sensor obtained by the preparation method of the present invention has the advantages of good affinity, strong specificity, good stability, low detection limit, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0036] Figure 1 is a SEM image of a sensor substrate electrode according to an embodiment of the present invention;
[0037] Figure 2 It is a schematic diagram of the SDS-PAGE electrophoresis identification results of the Nanobody in the embodiment of the present invention;
[0038] Figure 3 is a schematic diagram of the concentration results of the Nanobodies in the Examples of the present invention;
[0039] Figure 4 This is a schematic diagram of the effect of the inducer concentration on the Nanobody concentration in the embodiment of the present invention:
[0040] Figure 5 Schematic diagram of the effect of induction time on the concentration of Nanobodies in the examples of the present invention;
[0041] Figure 6 Schematic diagram of the effect of induction temperature on the concentration of Nanobodies in the examples of the present invention;
[0042] Figure 7 Schematic diagram of the effect of imidazole elution concentration on Nanobody concentration in the examples of the present invention;
[0043] Figure 8 Schematic diagram of the performance results of indirect ELISA analysis of nanoantibodies recognizing S protein in an embodiment of the present invention;
[0044] Fig. 9 Schematic diagram of the results of indirect ELISA analysis of the thermal stability of nanobodies in an embodiment of the present invention;
[0045] Fig.10 Schematic diagram of the results of indirect ELISA analysis of the chemical stability of nanobodies in an embodiment of the present invention;
[0046] Fig.11 Schematic diagram of the in-depth characterization of the chemical functional groups of MWCNTs and nano-antibody immunosensors by Fourier transform infrared spectrometer in the embodiment of the present invention;
[0047] Fig.12 Schematic diagram of the effect of coupling agent concentration on the results during sensor preparation in an embodiment of the present invention;
[0048] Fig.13 Schematic diagram of the effect of coupling pH value results during sensor preparation in an embodiment of the present invention;
[0049] Fig.14 Schematic diagram of the effect of antibody content on the sensor preparation process in an embodiment of the present invention;
[0050] Fig.15 Schematic diagram of the binding kinetics results of the electrochemical immunosensor in an embodiment of the present invention;
[0051] Fig.16 A schematic diagram of the quantitative detection results of the electrochemical immunosensor in an embodiment of the present invention;
[0052] Fig.17 A schematic diagram of the quantitative detection results of the electrochemical immunosensor in an embodiment of the present invention;
[0053] Fig.18 A schematic diagram of the specificity results of the immunosensor in an embodiment of the present invention;
[0054] Fig.19 A schematic diagram of the anti-interference results of the immunosensor in an embodiment of the present invention;
[0055] Fig. 20 A schematic diagram of the reproducibility results of the immunosensor in an embodiment of the present invention;
[0056] Fig.21 A schematic diagram of the stability results of the immunosensor in an embodiment of the present invention;
[0057] Fig. 22 Schematic diagram of the signal response results of the sensor of Comparative Example 1 of the present invention to the new coronavirus S protein;
[0058] Fig.23Schematic diagram of the signal response results of the nanoantibody immunosensor to the new coronavirus S protein in an embodiment of the present invention. DETAILED DESCRIPTION
[0059] In order to further illustrate the method adopted by the present invention and the effect achieved, the technical solution of the present invention will be clearly and completely described in combination with experiments below.
[0060] The novel nano-antibody electrochemical immunosensor and its preparation method and application provided in the embodiments of the present application relate to microbial identification and detection, and can be used to identify and detect microorganisms, especially viruses. Specifically, the nano-antibody electrochemical immunosensor is used to detect the environment (water body).
[0061] In order to solve the problems of long cycle, high cost, low safety, low stability and poor sensitivity of the existing detection methods in the background technology, the embodiment of the present application provides a new type of nano-antibody electrochemical immunosensor and its preparation method and application, wherein the biorecognition element in the sensor is a nano-antibody; the base electrode in the sensor is a glassy carbon electrode modified with carboxyl carbon nanotubes, and the sensor has the advantages of strong specificity, high stability and good sensitivity.
[0062] In combination with the above content, the following is a detailed solution of an embodiment of the present invention:
[0063] A novel nano-antibody electrochemical immunosensor, comprising: a biorecognition element for identifying a target protein, and a substrate electrode for loading the biorecognition element and converting the interaction between the biorecognition element and the target protein into an electrical signal;
[0064] The biorecognition element is a nano-antibody; the substrate electrode is a glassy carbon electrode modified with carboxyl carbon nanotubes;
[0065] The nanobody is obtained by recombining the gene of the virus containing the target protein with a prokaryotic expression vector to obtain a recombinant vector, and then expressing the recombinant vector in a prokaryotic manner.
[0066] The target protein is the new coronavirus S protein RBD, and the gene sequence of the gene of the virus containing the target protein is shown in SEQ ID NO: 1. The prokaryotic expression vector is a pET25b vector.
[0067] The preparation method of the novel nano-antibody electrochemical immunosensor comprises the following steps S1-S3
[0068] S1. Preparation of anti-COVID-19 S protein RBD antibodies;
[0069] S1-1, recombining the gene of the virus containing the target protein with the pET25b vector to synthesize a recombinant vector;
[0070] The gene sequence of the gene in the anti-COVID-19 S protein RBD antibody is shown in SEQ ID NO: 1;
[0071] SEQ ID NO: 1 is: >RBD-NB95
[0072] CcatggAACACCATCATCATCATCACCACCAAGTACAATTAGTAGAAAGCGGAGGAGGATTAGTACAAGCAGGAGGAAGCCTAAGACTAAGCTGCGCAGCAAGCGGAAGAACATTCAGCAGCTACAGCATGGGATGGTTCAGACAAGCACAAGGAAAGGAAAGAGAATTCGTAGCAACAATAAACGGAAACGGAAGAGACACATACTACACAAACAGCGT AAAGGGAAGATTCACAATAAGCAGAGACGACGCAACAAACACAGTATACCTACAAATGAACAGCCTAAAGCCAGAAGACACAGCAATATACTACTGCGCAGCAGACAAGGACGTATACTACGGATACACAAGCTTCCCAAACGAATACGAATACTGGGGACAAGGAACACAAGTAACAGTAAGCAGCTGGTCACATCCACAATTCGAAAAGTGATGActcgag.
[0073] S1-2. Transfer the recombinant vector into E. coli DH5α bacteria and induce expression and purify it to obtain anti-COVID-19 S protein RBD antibody.
[0074] First, the components and preparation methods of the culture medium involved in the following induction expression and purification are described:
[0075] LB liquid medium: 10 g peptone, 5 g yeast extract, 10 g NaCl, dissolved in 1000 mL distilled water, adjusted to pH = 7.0, sterilized at 121°C for 20 min.
[0076] LB solid medium: 10 g peptone, 5 g yeast extract, 10 g NaCl, 15-20 g (preferably 18 g in this embodiment) agar, dissolved in 1000 mL distilled water, adjusted to pH = 7.0, and sterilized at 121° C. for 20 min.
[0077] LB / Amp plate: Add ampicillin (Amp) at a final concentration of 100 μg / mL to sterile LB solid medium in an ultra-clean workbench, shake well and pour into a sterile culture dish, cover the dish and turn it upside down after solidification.
[0078] The above-mentioned recombinant vector transfer and induction expression include the following steps ①-③; purification includes the following steps 1)-4);
[0079] ① Preparation of competent cells
[0080] (1) E. coli. DH5α was streaked onto LB solid medium and then incubated at 37° C. for 12 to 16 hours (preferably 15 hours in this embodiment);
[0081] (2) picking a single colony from the cultured LB solid medium, inoculating it into a shaking tube containing 5 mL of LB liquid medium, and shaking culture at 37° C. and 220 rpm for 12 to 16 hours (overnight for 15 hours in this example) to obtain a culture;
[0082] (3) Take 500 μL of the culture in (2) and inoculate it into a conical flask containing 50 mL of LB liquid medium. Cultivate with shaking at 37°C and 220 rpm until the OD value reaches 0.4;
[0083] (4) Transfer the culture in the conical flask to a sterilized centrifuge tube and cool the culture to 0°C;
[0084] (5) Then, centrifuge the sample at 1000 g for 10 min at 4°C, discard the supernatant, drain the residual liquid on the tube wall, and resuspend the bacteria in 40 mL of pre-cooled 0.1 M MgCl2-CaCl2 (containing 20 mM MgCl2 and 80 mM CaCl2);
[0085] (6) Centrifuge the sample at 1000 g for 10 min at 4°C, discard the supernatant, drain the residual liquid on the tube wall, and then gently resuspend the bacteria in 500 μL of pre-cooled 0.1 M CaCl2;
[0086] (7) Sterile glycerol with a final concentration of 10% was added to the bacterial solution, and after thorough mixing, the mixture was cooled in an ice bath for 10 minutes to obtain competent cells, which were then stored in a -80°C refrigerator for later use.
[0087] ② Transformation of competent cells
[0088] (1) Thaw the competent cells, then take 10 μL of the ligation product and add 100 μL of the competent cells. Mix gently in a centrifuge tube and cool the mixture in an ice bath for 30 minutes.
[0089] (2) Transfer the centrifuge tube containing the mixture to a 42°C water bath for 90 seconds of heat shock, then quickly transfer the centrifuge tube to an ice bath for 2 minutes of cooling;
[0090] (3) Then, 800 μL of LB liquid medium pre-warmed to 37°C was added, and the mixture was shaken and cultured at 37°C and 150 rpm for 40 minutes; the mixture was centrifuged and resuspended in PBS to obtain the transformation product;
[0091] (4) Take 100 μL of the transformation product and add it to the LB / Amp plate. After spreading evenly, centrifuge the centrifuge tube at 12000 rpm for 1 minute, discard part of the supernatant, and add the remaining 100 μL of resuspended bacteria to the LB / Amp plate. Spread evenly again, invert, and culture at 37°C for 12 to 16 hours (15 hours overnight in this example). E. coli.DH5α / pET25b-Nb95 strain was obtained.
[0092] ③ Prokaryotic expression of nanobodies
[0093] (1) Take the E. coli.DH5α / pET25b-Nb95 strain, streak it on an LB / Amp plate, and invert and culture it at 37°C for 12 to 16 hours (in this example, overnight for 15 hours);
[0094] (2) Pick a single colony from the above LB / Amp plate and inoculate it into 5 mL LB / Amp liquid medium; culture it at 37°C, 220 rpm with shaking for 8 hours until it reaches the logarithmic growth phase (OD = 0.5-0.6);
[0095] (3) Take 500 μL of the cultured bacterial solution and inoculate it into 50 mL of LB / Amp liquid medium; continue to shake and expand the culture at 37°C and 220 rpm for 2.5 hours until it reaches the logarithmic growth phase;
[0096] (4) Then, 0.4-0.6 M (preferably 0.5 M) IPTG (isopropyl-β-D-thiogalactoside, inducer) was added to the culture, and the expression was induced at 15-25° C. (preferably 20° C. in this embodiment) and 180 rpm for 11-13 h (preferably 12 h in this embodiment);
[0097] (5) Transfer the culture after induction of expression in (4) to a 100 mL centrifuge tube, centrifuge at 4°C, 8000 rpm for 12 min, and discard the supernatant; then resuspend in 15 mL of 0.01 M PBS (phosphate buffered saline) and evenly distribute into two 10 mL centrifuge tubes;
[0098] (6) The aliquoted bacterial solution was subjected to ultrasonic disruption, centrifuged at 4°C, 8000 rpm for 15 minutes, and the supernatant was collected to obtain the disrupted bacterial supernatant containing the target protein.
[0099] purification:
[0100] 1) First, drain the preservation solution of the resin (also called medium or filler) in the affinity column used for purification; then add ultrapure water to wash the column 5 times, and add PBS buffer to wash the affinity column 5 times;
[0101] 2) Add the supernatant of the broken cells obtained in ③ above to Ni 2+ In the affinity column, collect the flow-through liquid and repeat the column twice to make the target protein fully hang on the column;
[0102] 3) Add PBS buffer to wash the supernatant remaining in the affinity column 5 times; then add 10 mL of 20 mM imidazole solution to wash the impurities adsorbed on the nickel ion affinity column;
[0103] 4) Add 10 mL of imidazole solution with a concentration of 180-210 mM (preferably 200 mM) to elute the target protein, and collect the imidazole solution in a 1.5 mL centrifuge tube to obtain anti-COVID-19 S protein RBD antibody.
[0104] S2, using carboxylated multi-walled carbon nanotubes to modify glassy carbon electrodes;
[0105] It should be understood that, in addition to the biorecognition element, the sensor usually includes a working electrode (i.e., a substrate electrode), a counter electrode, and a reference electrode, as well as a connector and an interface; wherein the substrate electrode is the main part of the electrochemical immunosensor, usually a conductive material; the substrate electrode provides a platform for fixing antibodies or other recognition elements. The reference electrode and the counter electrode refer to the fact that when performing electrochemical measurements, a reference electrode and a counter electrode are usually required. The reference electrode provides a stable potential reference, while the counter electrode is used to complete the circuit so that current can flow between the working electrode and the reference electrode. In addition, the sensor needs to be connected to an external device (such as an electrochemical workstation) for signal reading and processing. This is usually achieved through connectors and interfaces.
[0106] Illustratively, in an embodiment of the present invention, a glassy carbon electrode is used as the substrate electrode; a platinum wire electrode is used as the counter electrode; and an Ag / AgCl electrode is used as the reference electrode.
[0107] Before electrode modification and loading, the glassy carbon electrode needs to be placed in 5 mmol / L [Fe(CN)6] 3- / 4-In a solution (containing 0.1M KCl), cyclic voltammetry was performed in the potential range of -0.2 to 0.6V at a scan rate of 100mV / s until a stable CV spectrum was obtained, ensuring that the redox peak potential difference was within 100mV; after scanning, the treated glassy carbon electrode was obtained and dried with N2 for later use.
[0108] S2-1, dispersing the carboxylated multi-walled carbon nanotubes in an N,N-dimethylformamide solution to obtain a dispersion;
[0109] S2-2, evenly drop the dispersion onto the glassy carbon electrode and let it dry to obtain a carboxylated multi-walled carbon nanotube modified substrate electrode.
[0110] Specifically: 1 mg of carboxylated multi-walled carbon nanotubes was dispersed in 1 mL of organic solution N,N-dimethylformamide and ultrasonicated for 30 minutes, 0.05% of Nafion was added and dispersed evenly to obtain a dispersion; 8 μL of the dispersion was evenly drop-coated on the treated glassy carbon electrode by drop coating and dried at room temperature.
[0111] S3. Load the anti-COVID-19 S protein RBD antibody onto the glassy carbon electrode to obtain the sensor.
[0112] S3-1, using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide 2-morpholineethanesulfonic acid buffer to activate the glassy carbon electrode, and then rinse it with phosphate buffer saline for use;
[0113] Exemplarily, in the embodiment of the present invention, the electrode is first functionalized: the glassy carbon electrode is immersed in a MES (2-morpholineethanesulfonic acid) buffer (pH=7) containing 4 mM EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) and 8 mM NHS (N-hydroxysuccinimide), incubated at room temperature for 1 hour to complete the activation of the glassy carbon electrode, and the obtained electrode is rinsed with a PBS solution;
[0114] S3-2, mixing the anti-COVID-19 S protein RBD antibody in phosphate buffered saline to form an antibody solution;
[0115] Illustratively, in the embodiments of the present invention, specific monoclonal antibody / specific nanoantibody Nb95 was added to 0.01 M PBS buffer to prepare antibody solutions of 0.04 and 0.03 mg / mL, respectively.
[0116] S3-3. After mixing the antibody solution with the glassy carbon electrode treated in S3-1 and letting it stand, take out the glassy carbon electrode and immerse it in a bovine serum albumin solution for incubation, and then wash the glassy carbon electrode with a phosphate buffered saline solution to obtain the sensor.
[0117] Illustratively, in an embodiment of the present invention, the activated electrode is transferred to an antibody solution, incubated at room temperature for 1 hour, and washed three times with a PBS solution to successfully connect the specific antibody to the loaded glassy carbon electrode; the obtained modified electrode is immersed in a 3% (w / v) BSA solution and incubated for 1 hour to block the remaining active sites, and washed twice with a PBS solution to remove unbound BSA; the sensor is obtained and placed in a 4°C refrigerator for standby use after preparation.
[0118] The sensor is applied to the detection of the novel coronavirus S protein in water, and the detection method is:
[0119] Take 1 mL of water sample, and add 0.07 ng / mL and 0.1 ng / mL of new coronavirus S protein to the water sample, respectively. Place the sensor of the present invention in the water sample for incubation, record the peak current response before and after incubation, and calculate the recovery rate of the immunosensor for different concentrations of new coronavirus S protein.
[0120] Comparative Example 1: Monoclonal antibodies are used instead of the nanobodies in the above embodiment, and the above steps S2-S3 are performed to obtain the sensor of Comparative Example 1.
[0121] Experimental example:
[0122] Experimental Example 1: Characterization of Nanobodies;
[0123] Experimental Example 2, Characterization of Sensors;
[0124] Experimental Example 3: Sensor application in water body detection;
[0125] Among them, the characterization of the nanobody in Experimental Example 1 includes SDS-PAGE electrophoresis identification of the nanobody, concentration determination of the nanobody, the influence of induction and purification condition parameters, and characterization of immunoassay performance.
[0126] SDS-PAGE electrophoresis identification of nanoantibodies: Gel preparation: First pour in 12% separation gel, wait for it to solidify, pour in the concentrated gel until the liquid surface overflows, then insert the electrophoresis comb, and wait for the concentrated gel to solidify. Loading: Mix 30μL of purified protein solution with 10μL 4x Protein Loading Buffer, boil for 10 minutes, and centrifuge at 12000r / min for 10 minutes. Take 20μL of sample and load 5μL of pre-stained protein Marker in sequence. Electrophoresis: Run for 30 minutes under low voltage (70V) conditions, waiting for the protein sample to enter the separation gel. Then increase the voltage to 110V and continue running for 1 hour until the bromophenol blue dye reaches the bottom of the gel. Staining: Take out the protein gel, place it in Coomassie Brilliant Blue solution for staining, and stain on a shaker for 2 hours. Decolorization: Recover the staining solution, add the decolorizing solution, shake on a shaker for decolorization, and replace the decolorizing solution several times until it is completely decolorized. The identification result is: the unpurified expression product and the purified target protein (i.e., nanobody) are analyzed together using an SDS-PAGE kit; Figure 2 As shown, there are impurities in the unpurified protein band (a), while the purified target protein (b) has an obvious band at around 17 kDa and the band is single. The purification effect is good, which is consistent with the experimental expectations, indicating that the expression and purification effect of the nanobody is good.
[0127] Determination of the concentration of nanoantibodies: Use the BCA kit to determine the concentration of the protein. According to the instructions, add the standard sample and the sample to be tested to a 96-well plate, 25 μL per well, and set up three replicates. After mixing reagent A and reagent B of the working solution at a ratio of 50:1, add 200 μL to each well. After incubating at 37°C for 30 minutes, measure the absorbance at 562 nm (OD562) and draw a standard curve. Finally, by comparing the absorbance of the sample to be tested with the protein concentration of the corresponding absorbance on the standard curve, the protein concentration of the sample to be tested can be calculated. The concentration of the nanoantibody was determined by the BCA method, and a standard curve was drawn with the concentration of the standard sample (BSA) as the X-axis and the OD562 value as the Y-axis. The results are as follows. Figure 3 As shown, the linear equation is y=0.7783x+0.0867 (R2=0.9997), which has a good linear relationship. The concentration of the nanobody is calculated by substituting the measured sample OD562 value. After purification, the expression level of the nanobody reaches 493 μg / mL.
[0128] Effects of induction and purification parameters:
[0129] Inducer concentration: In the experiment, different concentrations of inducer IPTG (0.25M, 0.5M, 0.75M, 1M) were added to the bacterial solution to induce expression, and the bacteria were collected and broken by ultrasonic wave to keep the upper part. 2+After column purification, the expression effect of the antibody was analyzed by SDS-PAGE, and the concentration of the nanobody was determined by the BCA method to determine the optimal induction concentration of IPTG. Figure 4 As shown, after inducing expression with IPTG at different concentrations of 0.25M, 0.5M, 0.75M, and 1M, the expression amount of the supernatant was analyzed by SDS-PAGE (A) and concentration determination (B). As the IPTG concentration increased, the concentration of the nanoantibody increased accordingly. When the IPTG concentration was 0.5M, the antibody expression effect was the best. Therefore, the optimal IPTG concentration of 0.5M was selected for inducing expression in subsequent experiments.
[0130] Induction time: During the induction process, 0.5M IPTG was added to the bacterial solution, and the induction expression was performed for 6h, 8h, 10h, 12h, 14h, and 16h respectively. The collected bacteria were broken by ultrasonic wave and the supernatant was retained. 2+ After column purification, the expression effect of the antibody was analyzed by SDS-PAGE electrophoresis, and the concentration of the nanobody was determined by the BCA method to determine the optimal induction expression time. Figure 2-5 As shown in the figure, as the induction time increases, the concentration of nanoantibodies gradually increases. When the induction expression time is 12 hours, the color of the band is the darkest and the antibody expression is the largest. As the induction time increases, the expression amount decreases. Therefore, the optimal induction expression time of 12 hours was selected for subsequent experiments.
[0131] Induction temperature: After adding 0.5M IPTG to the bacterial solution, the cells were induced at 10℃, 15℃, 20℃, 25℃, and 30℃ for 12h, and the collected cells were broken by ultrasound. After purification, the expression effect of the antibody in the supernatant was analyzed by SDS-PAGE electrophoresis, and the concentration of the nanoantibody was determined by the BCA method to determine the optimal induction expression temperature. Figure 2-6 As shown, when the temperature increases from 10°C to 20°C, the expression level gradually increases, and further increase in temperature has an inhibitory effect on the expression level of the nanoantibody, so the optimal induction expression temperature is selected as 20°C.
[0132] Imidazole elution concentration: Gradient elution method was used, using 100mM, 150mM, 200mM and 250mM imidazole solutions of different concentrations. The effect of protein purification was analyzed by SDS-PAGE electrophoresis. The protein concentration was determined using the BCA method to determine the optimal imidazole elution concentration. The results are shown in Figure 2-7 As the imidazole concentration increases, the purity of the target protein gradually increases. When the concentration reaches 200mM, the protein elution effect is the best. Therefore, the optimal imidazole elution concentration is 200mM.
[0133] Characterization of immunoassay performance:
[0134] Indirect ELISA analysis of the performance of nanoantibodies in recognizing S protein: dilute the new crown S protein to a concentration of 1 μg / mL and add 100 μL per well to a 96-well ELISA plate. At the same time, 1 μg / mL of casein (OVA) and bovine serum albumin (BSA) were used as negative controls and incubated at 4°C for 12 hours. Pat the ELISA plate dry and wash the plate 3 times with 0.05% PBST, then add 300 μL of skim milk powder (5%) to each well to block the blank site and incubate at 37°C for 2 hours. Pat the ELISA plate dry and wash the plate 5 times with 0.05% PBST, and add 100 μL of 1, 0.5, 0.25, 0.125, 0.0625, 0.03125, 0.01563, 0.00782, 0 μg / mL of nanoantibodies to each well in turn, and incubate at 37°C for 1 hour. Pat the liquid in the wells dry and wash the plate 5 times with 0.05% PBST. Then add 100 μL of secondary antibody diluted 7500 times to each well, incubate at 37°C for 1 hour, then pat the ELISA plate dry and wash the plate 5 times with 0.05% PBST. Finally, add 100 μL of TMB colorimetric solution to each well and incubate at 37°C for 20 minutes. Add 50 μL of 2M H2SO4 to each well, terminate the reaction and immediately measure OD450 with a microplate reader. Different proteins were selected to evaluate the specificity of nanoantibodies, and BSA and OVA, structural analogs of the new crown S protein, were used as negative controls. First, the antigens were coated separately: new crown S protein, BSA and OVA, and after blocking with skimmed milk powder, the expressed nanoantibody (Nb95) was added, and the affinity and specificity of Nb95 binding to the new crown S protein were verified by the indirect ELISA method. The results are as follows. Figure 8 The nanoantibody only binds to the SARS-CoV-2 S protein, but not to BSA and OVA. As the concentration of the nanoantibody increases, its affinity to the SARS-CoV-2 S protein increases, indicating that the nanoantibody has good specificity.
[0135] Indirect ELISA analysis of the thermal stability of nanoantibodies: Nanoantibodies were compared with monoclonal antibodies against the new coronavirus. The purified nanoantibodies and monoclonal antibodies were diluted and heated at different temperatures (4°C, 25°C, 37°C, 50°C, 80°C) for 5 minutes. The ability of antibodies to bind to antigens before and after treatment was evaluated by enzyme-linked immunosorbent assay. The ELISA method is the same as 2.3.5.1, except that only 1 μg / mL of the new coronavirus S protein was added during the antigen coating process. The results are as follows: Fig. 9As shown in the figure, as the temperature rises, monoclonal antibodies gradually lose their binding ability, while the nanobodies expressed in this study can still maintain a certain ability to bind to antigens at a temperature of 80°C. Traditional antibodies, however, are exposed to their hydrophobic surfaces under high temperature conditions, which causes them to adhere to each other and form precipitation, destroying their original functions. Under extreme conditions, nanobodies will form a disulfide bond between CDR1 and CDR3, so that they can withstand extreme conditions such as high temperatures, and the longer the CDR3, the more stable the structure of the antibody. Therefore, compared with monoclonal antibodies, nanobodies have better thermal stability.
[0136] Indirect ELISA analysis of the chemical stability of nanobodies: In order to evaluate the chemical stability of nanobodies, the purified nanobodies and monoclonal antibodies were diluted and incubated in different pH buffers (10, 8, 7, 5, 3) for 2 h, and the ability of antibodies to bind to antigens before and after treatment was evaluated by enzyme-linked immunosorbent assay. Fig.10 As shown, nanobodies still show high stability and affinity at different pH levels, while traditional monoclonal antibodies gradually become inactivated. This is also attributed to the disulfide bonds in the nanoantibody structure, so they can withstand extreme conditions. Monoclonal antibodies cause their structure and function to be destroyed under extreme conditions, so nanoantibodies have better chemical stability.
[0137] Experimental Example 2, Characterization of Sensors;
[0138] The characterization of the sensor includes: characterization of the electrode surface morphology and characterization of the sensor preparation conditions, and characterization of the electrode surface morphology using scanning electron microscopy (SEM);
[0139] Electrode surface morphology characterization: SEM was used to characterize the morphology of the electrode loaded with nanoantibody Nb95. The results are as follows Figure 1 As shown in the figure, when the electrode surface is loaded with MWCNTs, it can be seen that the electrode surface presents a tubular, rough and irregularly arranged fiber strip morphology, indicating that MWCNTs are successfully modified on the electrode surface. After the subsequent coupling of nanoantibodies, there are spherical rough particles around the carbon nanotubes, indicating that the nanoantibodies are successfully coupled to the MWCNTs / GCE surface. The chemical functional groups of MWCNTs and nanoantibody immunosensors were deeply characterized by Fourier transform infrared spectroscopy, such as Fig.11,Through the FT-IR spectrum, it can be seen that the peak at 3437cm-1 is attributed to the -OH group, the peak at 1717cm-1 is attributed to the vibration stretching of -COOH, and the peak at 1236cm-1 is due to the vibration stretching of -C=O, which indicates that the modification of carboxylated carbon nanotubes is successful. After coupling with nanoantibodies, the peaks at 3270cm-1 and 1503cm-1 are related to the vibration of -NH, the peak at 1659cm-1 is due to the vibration stretching of -C=O, and the peak at 1383cm-1 is attributed to the stretching vibration of -CN bonds, indicating that the nanoantibodies are successfully coupled to the surface of carboxylated carbon nanotubes to form amide bonds, indicating that the nanoantibody immunosensor is successfully prepared.
[0140] Characterize the sensor preparation conditions;
[0141] Coupling agent concentration: including EDC / NHS concentration. EDC can activate the carboxyl group, so that it can react with small molecules containing amino groups (antibodies, peptides, etc.) to form stable amide bonds. The carboxyl group can react with EDC to form the intermediate product O-acylurea, but this product is unstable and easily hydrolyzed. Therefore, it must react in the presence of NHS to generate a stable intermediate NHS ester with amino-reactivity, thereby reducing the occurrence of hydrolysis and improving the reaction efficiency. It then reacts with primary amines to form stable amide bonds. The concentration of EDC-NHS is also an important influencing factor. Therefore, this experiment selected coupling agents with different concentrations of 1-2mM, 2-4mM, 3-6mM, 4-8mM, and 5-10mM, and measured the electrode peak current response values before and after coupling with different concentrations of EDC-NHS. The calculation formula is: ΔI = Current before coupling - Current after coupling; the results are as follows Fig.12 As shown, for monoclonal antibodies (A) and nanoantibodies (B), as the concentration of the coupling agent increases, the difference in peak current before and after coupling gradually increases, reaching the highest point when the EDC-NHS concentration is 4-8mM, and the peak current gradually decreases as the concentration increases again. This is because too little EDC-NHS will affect the number of carboxyl groups replaced by NHS ester groups, and the carboxyl groups cannot be fully activated, thereby further affecting the subsequent antibody coupling quantity. Excessive use will make it difficult to clean in the subsequent steps and affect the coupling reaction. Therefore, the concentration of the coupling agent EDC-NHS selected in the experiment is 4-8mM.
[0142] Coupling pH: The pH of the buffer solution has a crucial influence on the performance of the electrochemical immunosensor. The coupling reaction must be carried out at an appropriate pH, because too high or too low pH will have a great impact on biological molecules, thereby inhibiting the biological activity of the antibody. In order to study the optimal pH conditions for the coupling process, a series of experiments were conducted in the pH range of 6.0 to 8.0. PBS buffer solutions with pH values of 6, 6.5, 7, 7.5, and 8 were prepared as the medium for the antibody coupling reaction, and the peak current response values of the electrode before and after antibody coupling under different pH conditions were measured. In order to obtain a more stable immunosensor, this study optimized the pH value of the PBS buffer during the coupling process. Fig.13 It is the electrical signal response of the immunosensor before and after coupling the nanoantibody and monoclonal antibody in buffer solutions with different pH values. As can be seen from the figure, for monoclonal antibody (A), as the pH value increases, the peak current difference before and after the electrode is coupled with the antibody gradually increases, reaching the maximum value when the pH value is 6.5. As the pH value continues to rise, the peak current difference gradually decreases. This is because at low pH, the intermediate O-acylurea formed is very unstable and easily hydrolyzed; however, if the pH is too high, the intermediate O-acylurea may be hydrolyzed, or the generated NHS ester may be reduced, thereby reducing the reaction rate of the amino group and the intermediate, and then resulting in a reduction in the amount of antibody coupling. Therefore, for the coupling of monoclonal antibodies, the optimal pH value selected in this experiment is 6.5. For nanoantibodies (B), the peak current difference reaches the maximum value when the pH value is 7, and the peak current difference gradually decreases as the pH value continues to rise. Therefore, for the coupling of nanoantibodies, the optimal pH value selected in this experiment is 7.
[0143] Antibody content: The antibody content on the sensor surface has an important influence on the performance of the sensor. Too little content may lead to a reduction in the binding sites of the immune response, thereby affecting the sensor's detection performance for the target molecule. Therefore, ensuring an appropriate antibody concentration is one of the important factors affecting the performance of the immunosensor. This experiment investigated the effects of different concentrations of nanoantibodies and monoclonal antibodies on the performance of the immunosensor. The selected antibody concentrations were 0.005, 0.01, 0.02, 0.03, 0.04, and 0.05 mg / mL. The activated electrode was placed in antibody solutions of different concentrations for a period of time, and the DPV peak current changes before and after the antibody coupling were recorded. Fig.14(A, B), when the concentrations of monoclonal antibody and nano antibody reached 0.04 mg / mL and 0.03 mg / mL respectively, the peak current difference basically reached equilibrium. As the concentration increased further, the peak current difference gradually tended to be stable. The possible reason is that the nano antibody is smaller in size and can enter the grooves and cracks on the surface of the modified material, making it easier to combine with the carboxyl group to reach saturation. Therefore, the antibody concentration selected in the sensor preparation process of Comparative Example 1 is 0.04 mg / mL, and the antibody concentration selected in the nano antibody immunosensor preparation process is 0.03 mg / mL.
[0144] Binding kinetics of electrochemical immunosensor: The reaction between the successfully prepared electrochemical immunosensor and the new crown S protein depends on specific binding. In immunoassay, the length of the binding time has an important influence on the degree of completion of the immune response, thereby significantly affecting the electrical signal response of the electrochemical immunosensor. This experiment selected room temperature as the incubation temperature, and investigated the DPV peak current response of the sensor of comparative example 1 after incubation with the new crown S protein for 5, 10, 15, 20, 30, 40, and 50 minutes in a new crown S protein antigen solution with a concentration of 0.05 ng / mL at room temperature, and the DPV peak current response value after incubation of the nano-antibody immunosensor with the new crown protein for 3, 5, 7, 10, 15, 20, and 30 minutes. Calculation formula: ΔI = Current before incubation - Current after incubation; The results are as follows: Fig.15 As the incubation time increases, the redox peak current difference gradually increases. After reaching 30 minutes, the immune response basically tends to balance, and the peak current difference gradually stabilizes. Too long an incubation time will affect the binding efficiency of the immunosensor. Therefore, for the sensor of comparative example 1, the optimal immune response time is 30 minutes; as shown in Figure (B), for the nano-antibody immunosensor, after the incubation time reaches 20 minutes, the immune response basically reaches a balance, and the peak current difference gradually stabilizes with time. Too long an incubation time will affect the binding efficiency of the immunosensor. Therefore, for the nano-antibody immunosensor, this experiment selects 20 minutes as the optimal immune response time. Compared with the two immunosensors, the nano-antibody immunosensor has a shorter immune response time and a faster detection performance.
[0145] Electrochemical immunosensor quantitative detection: Under the above optimal experimental conditions, a series of different concentrations of the new crown S protein (0.02-0.4 ng / mL) were measured. The two electrochemical immunosensors (Comparative Example 1 and the embodiment of the present invention) were incubated in different concentrations of the new crown S protein solution, and the sensors were washed with PBS solution to remove non-specifically bound proteins. The DPV peak current response values of the two sensors after incubation with different concentrations of the new crown S protein solution were recorded. The results are as follows: Fig.16As shown in Figure (A), when the concentration of the new crown S protein is in the range of 0.02 to 0.4 ng / mL, the DPV redox peak current gradually decreases with the increase of the antigen concentration. Figure (B) shows the relationship between the peak current difference before and after the binding of the monoclonal antibody on the surface of the immunosensor to the antigen and the antigen concentration in the range of 0.02 to 0.4 ng / mL new crown S protein concentration. The concentration is within 0.02 to 0.15 ng / mL, and the peak current difference has a good linear relationship with the S protein concentration. The linear regression is ΔI=6.8×10-4C(ng / mL)+8×10-6(R2=0.9466). The detection limit (LOD) of the sensor of Comparative Example 1 is 10.2 pg / mL (S / N=3), the quantification limit (LOQ) is 33.8 pg / mL (S / N=10), and the sensitivity is 6.8×10-4A / (ng / mL);
[0146] like Fig.17 As shown in Figure A, when the concentration of the new coronavirus S protein is in the range of 0.02 to 0.25 ng / mL, the DPV redox peak current gradually decreases with the increase of the antigen concentration. Figure (B) shows that in the range of 0.02 to 0.15 ng / mL of the new coronavirus S protein concentration, there is a good linear relationship between the peak current difference before and after the binding of the nanoantibody to the antigen and the antigen concentration, and the linear regression equation is ΔI = 11.8×10-4C (ng / mL) + 2.6×10-6 (R2 = 0.9741). The detection limit (LOD) of the nanoantibody immunosensor is 7.1 pg / mL (S / N = 3), which is 3.1 pg / mL lower than the detection limit of the sensor in Comparative Example 1, and the limit of quantification (LOQ) is 23.7 pg / mL (S / N = 10), which is 29.9% lower than the LOQ of the sensor in Comparative Example 1, and the sensitivity is 11.8×10-4A / (ng / mL).
[0147] It can be seen from the results that the sensor of the embodiment of the present invention has lower detection limit and quantification limit, higher sensitivity and improved detection performance of the immunosensor compared with the sensor of comparative example 1.
[0148] Table 1 lists the methods for detecting SARS-CoV-2 using different electrochemical immunosensors. As can be seen from Table 1, the detection limits of the two immunosensors prepared in this study are comparable to those of the RT-PCR method, but the RT-PCR method requires multiple steps such as reverse transcription, and the operation requirements are relatively high, and rapid detection cannot be achieved. Therefore, the sensor prepared in this study has more advantages than traditional RT-PCR in environmental detection. Compared with other immunosensors, this sensor has a lower LOD (7.116pg / mL), such as the LOD of the sensor in the study of YAKOH A et al. is 0.11ng / mL; the immunosensor prepared in this study has a good linear range for the new crown S protein and a lower detection limit, and the preparation process and operation process are simpler and cheaper.
[0149] Table 1 Methods for detecting SARS-CoV-2 proteins
[0150]
[0151]
[0152] Specificity of immunosensors: In order to verify the specificity of the two electrochemical immunosensors (Comparative Example 1 and the embodiment of the present invention) in detecting the new coronavirus S protein, this experiment set up skimmed milk powder, casein, ovalbumin and bovine serum albumin as competitive proteins, and explored the specific recognition of the new coronavirus S protein by the two immunosensors. Under the optimal experimental conditions, the two immunosensors were placed in a solution of the new coronavirus S protein and competitive protein at a concentration of 0.1 ng / mL and a mixed solution of the above five substances. After incubation at room temperature for a period of time, they were washed three times with PBS solution to remove the influence of non-specific binding. The DPV peak current response values before and after incubation were recorded. The results are as follows. Fig.18As shown, the sensor of Comparative Example 1 has the largest current response in the new crown S protein solution, and the peak current difference is 75.6μA, which is 0.9, 5.2, 6.8, 6.3, and 8.0 times that of the five mixtures (80.9μA), bovine serum albumin (14.5μA), skimmed milk powder (11.2μA), ovalbumin (12.1μA), and casein (9.48μA), respectively. The difference in peak current response values between the mixed solution of the five substances and the solution containing only the new crown S protein is about 6.6%. The experimental results show that the constructed immunosensor has good specificity; for the nanoantibody immunosensor, the results are shown in Figure B, before and after incubation The nanoantibody immunosensor obtained the highest current response to the new coronavirus S protein, with a peak current difference of 112μA, which are 0.9, 7.9, 9.4, 11.5 and 10.1 times of the five mixtures (118μA), bovine serum albumin (14.2μA), skimmed milk powder (11.9μA), ovalbumin (9.7μA) and casein (11.1μA), respectively. In the mixed solution of the five substances, the difference in peak current response value with the solution containing only the new coronavirus S protein (5%) was smaller than the difference of the sensor in comparative example 1 (6.6%). The experimental results show that the nanoantibody immunosensor has better specificity than the sensor in comparative example 1.
[0153] Anti-interference of immunosensor: Since there are many pollutants in the sewage environment, including organic matter, inorganic matter and a large number of pathogenic microorganisms, in order to detect the anti-interference of the two successfully prepared immunosensors to different pollutants in sewage, this experiment selected several pollutants as interfering substances, such as bovine serum albumin (5mg / L, 25mg / L, 50mg / L), sodium chloride (0.35mg / L, 0.7mg / L, 3.5mg / L), glucose (5mg / L, 25mg / L, 50mg / L), humic acid (1mg / L, 5mg / L, 25mg / L), deoxyribonucleic acid (0.1mg / L, 0.5mg / L, 1mg / L). 0.05ng / mL of S protein was added to the above interfering substances, and the response values of DPV peak current before and after incubation of the two immunosensors were recorded.
[0154] For the nanoantibody immunosensor, the results are as follows Fig.19As shown in the figure, in bovine serum albumin solution (A), low concentration of BSA slightly increases the peak current difference of the immunosensor, which may be related to the sensor's ability to specifically recognize antigens. As the concentration increases, the peak current difference gradually decreases, but the sensor's recognition ability is still above 89.8%. In sodium chloride salt solution and glucose solution (B, C), as the concentration of interfering substances continues to increase, the response signal of the sensor gradually decreases. This may be due to the fact that during the incubation process, some interfering substances and nano-antibodies undergo non-specific adsorption and occupy the binding sites of the new crown S protein, resulting in a decrease in the peak current change, but the signal response is still between 83.2% and 98.3%, indicating that the immunosensor has good anti-interference. In humic acid, the interfering substances have no obvious effect on the sensor (D), the sensor has good specific recognition ability, and the peak current response signal is reduced by 10.2% at most. For deoxyribonucleic acid, the results are shown in Figure (E). The recognition ability of DNA to the new crown S protein of the sensor is inhibited to a certain extent. When the DNA concentration is 1 mg / L, the interference to the sensor is the greatest, and the peak current signal decreases by 10.4%, but a large number of antigens can still be detected. This experiment also studied the anti-interference of the immunosensor in a low-concentration single pollutant system. The results are shown in Figure (F). Compared with the mixed system, the interference in the single system has less effect on the sensor, and the maximum peak current change is 9.4μA. Therefore, the nanoantibody immunosensor has good anti-interference.
[0155] Reproducibility of immunosensors: Whether an immunosensor is reproducible is one of the important indicators for evaluating sensor performance. It can evaluate the minimum difference in measurement results. In order to detect the reproducibility of the two immunosensors prepared in this study, the experiment was carried out under the same environment. Five immunosensors of the same batch were prepared using the same method. The 0.1 ng / mL new coronavirus S protein was measured, and the peak current difference before and after incubation was recorded by the DPV method to compare the consistency between the electrodes. The results are as follows: Fig. 20 As shown, the two sensors were tested five times respectively, and the results were relatively stable. It was calculated that the RSD of the sensor of comparative example 1 was 4.0%, and the RSD of the nanoantibody immunosensor was 3.1%. Compared with the two, the reproducibility of the nanoantibody immunosensor was slightly better than that of the sensor of comparative example 1, and the difference between the electrodes was smaller.
[0156] Stability of immunosensors: Since monoclonal antibodies and nanoantibodies have the activity of binding to antigens, they may be affected by various factors during application, which may cause the protein structure of the antibodies to denature. In order to evaluate the stability of the two electrochemical immunosensors, this experiment examined the stability of the electrodes after being placed at a certain temperature for a period of time; the successfully prepared immunosensors were stored in an environment of 4°C for 20 days, and the DPV method was used to measure the peak current response value of the electrochemical immunosensor every two days and compare it with the original blank value. The results are as follows Fig.21 As shown, for the sensor (A) of Comparative Example 1, the peak current response value decreased by 29.04% after 20 days of storage. For the nano antibody immunosensor (B), the results showed that a high current response was still maintained after 20 days, and the peak current response value only decreased by 8.9%. The immunosensor can still retain 91.1% of the electrochemical activity. This is because the disulfide bonds inside the nano antibody help it maintain the stability of its conformation in harsh environments. Therefore, this sensor has better stability than the sensor of Comparative Example 1.
[0157] Experimental Example 3: Sensor application in water body detection;
[0158] Detection of actual samples: In the experiment, the sewage sample was first filtered through a 0.22μm filter membrane to ensure the removal of particulate matter and suspended matter in the sample. Then 1mL of the filtered water sample was taken, and 0.07 and 0.1ng / mL of the new coronavirus S protein were added to the water sample, respectively, to ensure that the sample contained the target detection object. Subsequently, the two successfully prepared immunosensors were placed in the water sample and incubated at room temperature for a period of time. The DPV method was used to record the peak current response before and after incubation, and the recovery rate of the immunosensor to different concentrations of new coronavirus S protein was calculated.
[0159] The sensor of Comparative Example 1 ( Fig. 22 ), in the sewage inlet water sample with a new crown S protein concentration of 0.1ng / mL, the signal response of the immunosensor to the new crown S protein changed greatly compared with the buffer solution, while the signal response in the sewage effluent and Yangtze River water samples changed less. This may be because the sewage inlet water sample contains more interferents, which affects the efficiency of antibody recognition of antigens, thus resulting in a decrease in the peak current difference. New crown S protein standards of different concentrations were added to sewage samples for detection. The experimental results are shown in Table 2. New crown S protein was detected in different samples, with a recovery rate between 89.4% and 105.0%, and an RSD in the range of 2.4% to 4.8%, indicating that the sensor can be used for actual sewage detection.
[0160] Table 2 Detection of COVID-19 S protein in actual water samples
[0161]
[0162] Embodiment of the present invention: For nano antibody immunosensor ( Fig.23 ), the new coronavirus S protein was detected in sewage inlet, sewage effluent and Yangtze River water samples, and the signal response changed little. The new coronavirus S protein standards of different concentrations were added to sewage samples for detection. The experimental results are shown in Table 3. The new coronavirus S protein was detected in samples of different concentrations, with a recovery rate between 93.1% and 103.7%, and an RSD in the range of 1.6% to 4.9%, indicating that the sensor can be used for the detection of actual sewage.
[0163] Table 3 Detection of COVID-19 S protein in actual water samples
[0164]
[0165]
[0166] The recovery rate of the sensor of Comparative Example 1 is between 89.4% and 105.0%, and the RSD is between 2.4% and 4.8%. The recovery rate of the nanoantibody immunosensor of the embodiment of the present invention is between 93.1% and 103.7%, and the RSD is between 1.6% and 4.9%, indicating that the immunosensor can be used for the detection of actual sewage, and the results of the present invention are more preferred.
Claims
1. A novel nano-antibody electrochemical immunosensor, characterized in that: The sensor comprises: a biorecognition element for identifying a target protein, and a substrate electrode for carrying the biorecognition element and converting the interaction between the biorecognition element and the target protein into an electrical signal; The biorecognition element is a nano-antibody; the substrate electrode is a glassy carbon electrode modified with carboxyl carbon nanotubes; The nanobody is obtained by recombining the gene of the virus containing the target protein with a prokaryotic expression vector to obtain a recombinant vector, and then prokaryotically expressing the recombinant vector; The target protein is the SARS-CoV-2 S protein RBD, and the sequence of the gene of the virus containing the target protein is shown in SEQ ID NO:
1.
2. A novel nano-antibody electrochemical immunosensor as claimed in claim 1, characterized in that: The prokaryotic expression vector is a pET25b vector.
3. The method for preparing a novel nano-antibody electrochemical immunosensor according to claim 2, characterized in that: include: S1. Preparation of anti-COVID-19 S protein RBD antibodies; S2, using carboxylated multi-walled carbon nanotubes to modify glassy carbon electrodes; S3. Load the anti-COVID-19 S protein RBD antibody onto the glassy carbon electrode to obtain the sensor.
4. The method for preparing a novel nano-antibody electrochemical immunosensor according to claim 3, characterized in that: S1, preparing anti-COVID-19 S protein RBD antibody comprises: S1-1, recombining the gene of the virus containing the target protein with the pET25b vector to synthesize a recombinant vector; S1-2. Transfer the recombinant vector to E.coli.DH5α bacteria for induced expression and purification to obtain anti-COVID-19 S protein RBD antibody.
5. The method for preparing a novel nano-antibody electrochemical immunosensor according to claim 4, characterized in that: The induction expression conditions in S1-2 are: using isopropyl-β-D-thiogalactoside as an inducer, the concentration of isopropyl-β-D-thiogalactoside is 0.4-0.6M, the induction time is 11-13h, and the induction temperature is 15-25°C; During the purification process, the concentration of the imidazole solution used to elute the anti-COVID-19 S protein RBD antibody is 180-210 mM.
6. The method for preparing a novel nano-antibody electrochemical immunosensor according to claim 3, characterized in that: The S2, using carboxylated multi-walled carbon nanotubes to modify the substrate electrode comprises: S2-1, dispersing the carboxylated multi-walled carbon nanotubes in an N,N-dimethylformamide solution to obtain a dispersion; S2-2, evenly drop the dispersion onto the glassy carbon electrode and let it dry to obtain a carboxylated multi-walled carbon nanotube modified substrate electrode.
7. The method for preparing a novel nano-antibody electrochemical immunosensor according to claim 3, characterized in that: S3, loading the anti-COVID-19 S protein RBD antibody onto the glassy carbon electrode to obtain the sensor comprises: S3-1, using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide 2-morpholineethanesulfonic acid buffer to activate the glassy carbon electrode, and then rinse it with phosphate buffer saline for use; S3-2, mixing the anti-COVID-19 S protein RBD antibody in phosphate buffered saline to form an antibody solution; S3-3. After mixing the antibody solution with the glassy carbon electrode treated in S3-1 and letting it stand, take out the glassy carbon electrode and immerse it in a bovine serum albumin solution for incubation, and then wash the glassy carbon electrode with a phosphate buffered saline solution to obtain the sensor.
8. The use of a novel nano-antibody electrochemical immunosensor as claimed in claim 1, characterized in that: The sensor is applied to non-disease detection of the S protein of the new coronavirus in water.
Citation Information
Patent Citations
SARS-CoV-2 spike protein fragment polyploid as well as preparation method, detection reagent kit, vaccine and medicine thereof
CN112048005A
High-stability novel coronavirus spike protein, related biological material, application of related biological material, detection test paper and detection kit
CN112079906A
Electrochemical aptamer sensor for detecting SARS-CoV-2 based on CRISPR / Cas12a
CN114047243A
Magnetic carbon nanotube for extracting nucleic acid and application thereof
CN115274235A
Manufacturing method of nanovesicle comprising an olfactory receptor protein from mammalia ...
KR1020120083987A
